How to explain the 'watch-and-wait' period to a CLL patient?
Discussion of a Phase III trial evaluating the efficacy and safety of idelalisib
Challenges in CLL - Richter's transformation and acute leukemia
ASCO 2016 highlights for CLL
Importance of prognostic factors in the treatment of CLL and how to assess them